Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Repressor element-1 silencing transcription factor (REST), also known as neuron-restrictive silencer factor (NRSF), is a Kruppel-type zinc finger transcription factor that represses genes involved in neuronal differentiation and function by binding to DNA at neuron-restrictive silencer elements (NRSE/RE1)[1][2][3][9]. REST is a master negative regulator of neurogenesis, present at high levels in non-neuronal tissues, and represses neuronal genes while its downregulation is necessary for neuronal development and maturation[1][2][5]. The REST protein exerts its function by recruiting chromatin-modifying enzymes, including histone deacetylases and demethylases, leading to epigenetic silencing of its target genes[1][3][8][9]. REST regulates thousands of target genes, including those encoding for neurotransmitter receptors, synaptic proteins, ion channels, and cell adhesion molecules[2][3]. It plays a role in chromatin plasticity, alternative mRNA splicing, and stress response to hypoxia and ischemia[1][7]. Dysregulation or mutation of REST is implicated in cancer, neurodegenerative conditions (e.g., Huntington's and Alzheimer's diseases), epilepsy, ischemic injury, and other pathologies[1][2][5]. Though not a direct target of current approved drugs, REST-modulating strategies are under research for neuroprotection and cancer therapy[1][2][3][5].
Transcriptional repression by recruitment of chromatin-modifying enzymes (e.g., histone deacetylases), epigenetic remodeling, modulation of gene expression through DNA binding at RE1/NRSE sites[1][3][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Repressor element-1 silencing transcription factor (REST).